Aspire Biopharma Holdings (ASBP) Q1 2025 Annual Earnings

Screener

Reported May 14, 2025 · Before market open

EPS-$0.42

Next report

Date not yet announced

Versus estimates

Revenue

Q2 2026$63.1K Q1 2026$28.4K Q4 2025$4.3K Q3 2025$1.9K

Diluted EPS

Q2 2026-$1.00 Q1 2026-$20.57 Q4 2025-$1.33 Q3 2025-$1.60 Q2 2025-$0.04

Q1 2025-$0.42

FAQ

When did Aspire Biopharma Holdings report Q1 2025 earnings?: Aspire Biopharma Holdings (ASBP) reported Q1 2025 earnings on May 14, 2025 before market open.
What were Aspire Biopharma Holdings's Q1 2025 revenue and EPS?: Aspire Biopharma Holdings reported eps of $-0.42 for Q1 2025.
How did Aspire Biopharma Holdings's Q1 2025 results compare year-over-year?: Compared to the same quarter a year prior, eps declined 512.2% from $-0.07.
Where can I find Aspire Biopharma Holdings's Q1 2025 SEC filings?: You can read the 10-K periodic report (0001641172-25-002917) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment Aspire Biopharma Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk